{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:03:03Z","timestamp":1747206183809,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["COPD"],"DOI":"10.2147\/copd.s172408","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T21:40:55Z","timestamp":1537306855000},"page":"2917-2929","source":"Crossref","is-referenced-by-count":5,"title":["Effect of background long-acting beta<sub>2<\/sub>-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-9036","authenticated-orcid":true,"given":"Edward M","family":"Kerwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-7178","authenticated-orcid":true,"given":"Robert","family":"Tosiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-436X","authenticated-orcid":true,"given":"Shahin","family":"Sanjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,9]]},"container-title":["International Journal of Chronic Obstructive Pulmonary Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=44554","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=44554","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T21:40:56Z","timestamp":1537306856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/effect-of-background-long-acting-beta2-agonist-therapy-on-the-efficacy-peer-reviewed-article-COPD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/copd.s172408","relation":{},"ISSN":["1178-2005"],"issn-type":[{"type":"electronic","value":"1178-2005"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}